As of 2025-11-01, the Relative Valuation of TCR2 Therapeutics Inc (TCRR) is (63.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.48 USD, the upside of TCR2 Therapeutics Inc based on Relative Valuation is -4415.5%.
The range of the Relative Valuation is (63.72) - (63.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 15.5x | 15.4x |
| Forward P/E multiples | 15.3x - 15.4x | 15.4x |
| Fair Price | (63.72) - (63.89) | (63.87) |
| Upside | -4405.7% - -4416.9% | -4415.5% |
| Date | P/E |